|Year : 2016 | Volume
| Issue : 46 | Page : 297-302
Screening of Chonemorpha fragrans bioactive extracts for cytotoxicity potential and inhibition studies of key enzymes involved in replication
Pradnya Prakash Kedari, Nutan Padmanabh Malpathak
Department of Botany, Savitribai Phule Pune University, Pune, Maharashtra, India
|Date of Submission||19-Nov-2015|
|Date of Decision||28-Dec-2015|
|Date of Web Publication||7-Jul-2016|
Nutan Padmanabh Malpathak
Department of Botany, Savitribai Phule Pune University, Ganeshkhind Road, Pune - 411 007, Maharashtra
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Chonemorpha fragrans (Moon) Alston, a liana belonging to family Apocynaceae, is used in traditional medicinal systems for the treatment of various ailments. It is an unexplored medicinal plant with respect to its anticancer potential. Objective: Cytotoxicity of sequential as well as crude extracts of in vivo plant parts (leaves, bark, and roots), in vitro cultures, and callus were compared. Materials and Methods: 3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cell proliferation assay was used to compare the extracts of various in vivo plant parts (leaves, bark, and roots) along with in vitro culture systems (in vitro plantlets, callus). Furthermore, the extracts were used to evaluate inhibition of key enzymes involved in replication, i.e. topoisomerase (Topo) I and II, DNA polymerase, to check the probable mechanism of action for this cytotoxicity. Results: MTT assay showed that the chloroform extract of callus has potent anticancer potential. The plant has a promising anticancer activity against human colon epithelium, lung carcinoma, and epidermoidal carcinoma cell lines. It was found to possess Topo as well as DNA polymerase inhibitory activity. Conclusion: The results have pointed toward pharmaceutical importance of this plant. This study is the first report of exploring the antiproliferative potential as well as inhibition studies of key enzymes involved in replication, which was useful to point out probable mechanism of action for extracts of C. fragrans.
Keywords: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, Chonemorpha fragrans, DNA polymerase, inhibitory activity, topoisomerase I and II
|How to cite this article:|
Kedari PP, Malpathak NP. Screening of Chonemorpha fragrans bioactive extracts for cytotoxicity potential and inhibition studies of key enzymes involved in replication. Phcog Mag 2016;12, Suppl S3:297-302
|How to cite this URL:|
Kedari PP, Malpathak NP. Screening of Chonemorpha fragrans bioactive extracts for cytotoxicity potential and inhibition studies of key enzymes involved in replication. Phcog Mag [serial online] 2016 [cited 2019 Aug 24];12, Suppl S3:297-302. Available from: http://www.phcog.com/text.asp?2016/12/46/297/185708
- It's a first report of cytotoxicity studies and inhibition of enzyme involved in the replication process by Chonemorpha fragrans plant extracts. The results reveal the pharmaceutical importance of this plant. From various assays performed here, a potent anticancer potential of chloroform extract of callus was revealed showing Topo I (E. coli and human) inhibitory activity, DNA pol inhibitory activity. Considering the importance of these activities, plant further needs to be explored in detail for in vivo cancer studies as well as for its metabolite content.
| Introduction|| |
Chonemorpha fragrans (Moon) Alston is a liana belonging to family Apocynaceae. It is known to possess diverse biological activities including muscle relaxant, antiparasitic properties, and antihyperglycemic effect.C. fragrans is also used in traditional systems of medicines for the treatment of different ailments such as gynecological disorders, skin diseases and inflammations, and fever and stomach disorder. In spite of traditional use in the treatment of variety of ailments, metabolic content of plant has not been explored. Phytochemical analysis of C. fragrans has revealed the presence of alkaloids, such as camptothecin (CPT), chonemorphine, and funtumafrine. CPT is a plant-derived monoterpene indole alkaloid, currently is in clinical use for the treatment of various types of cancer. This compound exhibits a broad spectrum of antitumor activity in the treatment of lung cancer, uterine cervical cancer, and ovarian cancer. According to Vijayan et al., steroidal alkaloids are also responsible for anticancer potential of plant extract. Such steroidal alkaloids of plant origin have potential as cytotoxic drugs for treating multidrug resistant cancer.
We know from literature that severe side effects of chemotherapeutic agents and increasing recurrence of tumors reduce the clinical effectiveness of a large variety of currently used anticancer agents. Also, acquired resistance of tumor cells to multiple cytotoxic drugs is a major cause of failure of cancer chemotherapy. Hence, there is a constant need to develop alternative anticancer drugs with minimal side effects. Anticancer agents derived from natural sources are preferred over chemical agents due to their effectiveness for cancer prevention and therapeutics.
Considering these facts, we have attempted to unveil the cytotoxicity potential of C. fragrans using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Instead of using a conventional approach for evaluating the cytotoxicity of crude plant extract, we have followed different approach wherein the sequential and crude extracts of variousin vivo plant parts (leaves, bark and roots) along within vitro culture and callus were compared. In cancer, cell begins to divide uncontrollably. Inhibiting the key enzymes in this division process can slowdown or hinder this uncontrolled cell division. Therefore, the work was further extended to disclose inhibitory activity of such enzymes such as topoisomerase (Topo) I and II, DNA polymerase (DNA pol) which play a key role in replication. This has also helped in evaluation of probable mechanism for this cytotoxicity.
| Materials and Methods|| |
Preparation of plant extracts of Chonemorpha fragrans
Plant was identified and authenticated by Botanical Survey of India, Pune (Voucher Specimen No. BSI/WRC/Cert./2015/PK01).In vivo plant parts (leaves, bark, and roots) of C. fragrans in vitro shoots grown on B5 medium supplemented with 2.2 mg/l 6-Benzylaminopurine and callus grown on B5 medium supplemented with 2.2 mg/l BAP + 0.6 mg/l 1-Naphthaleneacetic acid were shade-dried and were coarsely powdered using grinder. The extracts were prepared according to Kedari and Malpathak. All the obtained fractions were dissolved in 100 mg/ml of 0.1% dimethyl sulfoxide (DMSO) and diluted to yield various final working concentrations. These extracts were filtered using a 0.45 µm cellulose nitrate membrane and stored at −20°C till further analysis was carried out.
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide cell proliferation assay
MTT assay standard method was used to assess cell viability. L929 (Murine fibroblast cell line), HT29 (human colon epithelium), A549 (human lung carcinoma), and A431 (human skin epithelium) were chosen to evaluate cytotoxicity by means of MTT assay. All the cell lines were procured from National Centre for Cell Science, Pune, India.
1.0 × 105 cells/well were seeded in 96-well microtiter plates. After incubation with various extracts (2 µg, 4 µg, 6 µg, 8 µg of each extract) for 24 h, 50 μl MTT was added to each well and the plates were incubated for additional 4 h at 37°C. To achieve solubilization of the formazan crystal formed in viable cells, 200 μl DMSO was added to each well-followed by gentle shaking. Absorbance was read at 550 nm and surviving cell fraction was calculated. 0.1% DMSO was used as negative control and CPT was used as positive control. Data are presented as mean ± standard deviation (SD) of 3 experiments. Different letters within a column for a particular treatment represent significance at P < 0.05. The inhibition of cell was calculated by following formula:
% Inhibition = ([AC− AS]/AC) ×100
where, AC= Absorbance of control
AS= Absorbance of standard/extracts
Determination of topoisomerase inhibitory activity
Topoisomerase I (Escherichia coli) inhibitory activity
Topo I inhibitory activity was determined using Escherichia coli Topo I (New England Biolabs). Reactions were carried out as described by Diwan and Malpathak  method.
Topoisomerase I (human) inhibitory activity
Topo I inhibitory activity was determined using Human Topo I (TopoGEN). Reactions were carried out as described by Diwan and Malpathak  method.
Topoisomerase II (human) inhibitory activity
Inhibitory activity of test compounds on Topo II (Topo GEN) activity was evaluated by detecting the conversion of supercoiled pUC19 DNA to monomer as described by Snapka et al(1998).
DNA polymerase inhibitory activity
The procedure for assaying DNA pol inhibitory activity involves use of fluorescence dye PicoGreen with double-stranded DNA as described by Tveit and Kristensen. PicoGreen dsDNA quantitation reagent was purchased from Invitrogen (USA), E. coli DNA pol I large fragment (Klenow fragment) was purchased from fermentas. The method described here allows quantitation of polymerase activity exemplified by the Klenow fragment of DNA pol I from E. coli at reaction temperatures between 37°C and 72°C.
Primer template annealing
The annealed primer template mixture 1.0 pmole and 1.5 pmole (forward and reverse primers) was mixed with 2 mM each dNTP's, ×10 reaction buffer, and the final volume was made to 20 μl by adding sterile distil water. The reaction was initiated by addition of 0.05 U of DNA pol (Klenow fragment) to the above mixture. The reaction mixture was incubated for 30 min at 37°C. The reaction was stopped by addition of 0.25 M ethylenediaminetetraacetic acid (EDTA) followed by 100 μl of TE (10 mM Tris-HCl, pH 7.5, 1 mM EDTA) and 100 μl of Picogreen solution in TE. This mixture was incubated for 5 min and fluorescence was estimated using Pro5 (Molecular probes) spectrometer at 538 nm using an excitation wavelength of 485 nm.
The data are expressed as mean ± SD for at least three independent determinations in triplicate for each experimental point. SPSS (Version 18.0, Chicago, IL, USA) was used for all statistical analyses.
| Results|| |
3-(4,5-dimethylthiazol-2-yl)-2,5 -diphenyltetrazolium bromide cell proliferation assay
In the current study, we initially investigated the effects of several extracts on the viability of human cancer cell lines of various origins, including HT29 (human colon epithelium), A549 (human lung carcinoma), and A431 (human skin epithelium) cell lines. To check the adverse effect of these extracts on normal cells, these results were compared with the effect of extracts on normal cell line L929 (murine fibroblast cell line).
In vivo (root, bark, and leaves) extracts showed high inhibition of cells as compared toin vitro(in vitro shoots and callus) extracts on L929 cell line. Highest cytotoxicity was seen in chloroform extract of root (25.37%) at 6 µg, methanol extract of bark (24.505%) at 2 µg, ethyl acetate extract of bark (24.089%) at 6 µg, and equivalent to CPT (20.86%) at 8 µg [Figure 1]a. The lowest activity was observed in chloroform extract ofin vitro shoot (0.08%) at 2 µg, methanol extract of callus (0.83%) at 4 µg.
|Figure 1: (a) Cytotoxic effect of in vivo and in vitro extracts of Chonemorpha fragrans on cell line L929; (b) cell line HT29; (c) cell line A549; and (d) cell line A431|
Click here to view
In HT29, maximum inhibition of cells were observed byin vitro cultures, i.e., chloroform extract of callus (15.77%) at 2 µg, hexane extract ofin vitro shoot (14.70%) at 8 µg, ethyl acetate extract ofin vitro shoot (14.06%) at 6 µg, methanol extract of callus (13.89%) at 4 µg, ethyl acetate extract of callus (12.96%) at 8 µg, and hexane extract of callus (12.36%) at 4 µg [Figure 1]b. These extracts showed higher inhibition of HT29 cell line than standard CPT (7.96%) at 6 µg. Lowest activity was shown byin vivo extracts such as hexane extract of root (1.42%) at 8 µg and ethyl acetate extract of leaves (1.568%) at 8 µg.
In case of cell line A549% inhibition ranged from 1 to 18% [Figure 1]c. Highest activity was seen by ethyl acetate extract ofin vitro shoots (17.68%) at 6 µg concentration, chloroform extract ofin vitro shoot (11.665%) at 2 µg, chloroform extract of callus (11.67%) at 8 µg, and hexane extract ofin vitro shoots (14.48%) at 4 µg. Similar to HT29 cell line,in vitro shoot and callus extracts were effective as compared toin vivo plant part extracts (root, bark, and leaves) on A549 cell line.
The present inhibition of A431 ranged from 5 to 15% of inhibition [Figure 1]d. For all the analyzed extracts, percent inhibition was higher than standard CPT (7.90%) at 6 µg. The maximum activity was shown by chloroform extract of roots (15.94%) at 2 µg, hexane extract of callus (13.185%) at 4 µg, ethyl acetate extracts of leaves (12.45%) at 8 µg, and methanol extract of callus (11.75%) at 4 µg. Lowest cytotoxicity was shown by chloroform extract of roots (1.148%) at 6 µg, hexane extract of bark (1.58%) at 4 µg.
Percent inhibition of these extracts was at least twice to that of the standard CPT (4.468%) at 8 µg. Lowest activity was seen by methanol extract of leaves (0.33%) at 8 µg extract. In this case,in vitro shoots and callus extracts were effective thanin vivo plant extracts (root, bark, leaves).
Escherichia coli topoisomerase I inhibitory activity
As seen from [Figure 2]a, extracts showed retention of supercoiled form of DNA suggesting the inhibitory activity of C. fragrans extracts against Topo I. In ethyl acetate (Lane V), chloroform (Lane W), and hexane (Lane X) extract of callus, it is clearly seen that there is very low Topo I activity or no relaxed form.
|Figure 2: Lane A-E (a) Coli topoisomerase I inhibition by extracts of Chonemorpha fragrans; (b) human topoisomerase I inhibition; (c) human topoisomerase II inhibition, (reproduction size 11.9 cm × 15.4 cm) Lane A: Supercolied pUC 19 DNA, Lane B: DNA + topoisomerase enzyme, Lane C: 1 μg camptothecin, Lane D: 0.1% dimethyl sulfoxide, Lane E-X: DNA + topoisomerase + 2 μg/test compound, E-H: Root MeOH, EtOAc, CH3Cl, C6H12 extracts resp., Lane I-L: Bark MeOH, EtOAc, CH3Cl, C6H12 extracts, respectively, Lane M-P: Lvs MeOH, EtOAc, CH3Cl, C6H12 extracts, respectively, Lane Q-T: In vitro MeOH, EtOAc, CH3Cl, C6H12 extracts, respectively, Lane U-X: Callus MeOH, EtOAc, CH3Cl, C6H12 extracts, respectively. (R) Relaxed and (S) supercoiled plasmids|
Click here to view
In vitro shoot extracts (Lane Q–T) showed weak inhibition of Topo I activity while the crude methanol extracts of roots (Lane E), bark (Lane I) leaves (Lane M), and callus (Lane U) did not inhibit the activity of Topo I and caused complete relaxation of plasmid DNA indicating that allin vitro shoots extracts were weak inhibitors of Topo I and allowed Topo I to relax the plasmid DNA. We can observe that root (Lane F–H) and bark (Lane J–L) sequential extracts are also inhibitors of Topo I. Leaves (Lane N–P) sequential extracts have shown Topo I inhibition as well.
Human topoisomerase I inhibitory activity
Although the extracts vary in inhibiting E. coli Topo I, in case of human Topo I, all the extracts showed inhibitory activity. All the root, leaf, and callus extracts showed inhibitory activity comparable to CPT (2 µg/ml) (Lane C) [Figure 2]b. Bark (Lane I–L) andin vitro shoot (Lane Q–T) possessed weak activity. Ethyl acetate (Lane V) and hexane (Lane X) extract of callus showed strong activity. Ethyl acetate extract of bark (Lane J) and leaves (Lane N) showed strong inhibition of human Topo I.
Human topoisomerase II inhibitory activity
The assay results showed that all the extracts formed monomers of relaxed plasmid [Figure 2]c.
DNA polymerase inhibitory activity
Evaluation of C. fragrans extracts for DNA pol inhibitory assay revealed that the highest activity was seen in methanol extract of roots (82.54%) at 6 µg, chloroform extract of roots (72.22%) at 100 µg, methanol extract of bark (87.85%) at 8 µg, hexane extract of bark (87.10%) at 8 µg, methanol extract of leaves (85.087%) at 4 µg, and chloroform extract ofin vitro shoots (86.79%) at 4 µg concentration [Figure 3].
| Discussion|| |
The objective of this study was to investigate and compare cytotoxic activity of in vivo,in vitro shoot and callus sequential extracts of C. fragrans. The National Cancer Institute, USA, has listed most common types of cancer. Cell lines were chosen for most common types of cancer and were used for studying the effect of our extracts. L929, murine fibroblast cell line is a normal cell line in comparison to which the other cancerous cell lines A431, A549, and HT29 were analyzed. Different extracts of the plant exhibited varying activity on different cell lines. Lack of morphological differentiation of plants leads to change in the regular metabolic pathways. This can contribute to change in the metabolic content of an extract causing varying degree of anticancer activity.
Unlike cell line L929, in all the other cell lines, proliferation was strongly inhibited byin vitro shoots and callus extracts which was significantly higher than standard CPT (≥90% pure, Sigma-Aldrich). Standard CPT, which is clinically used in the treatment of various cancers, showed 15% inhibition for cell line L929 whereas it showed 5–10% inhibition level for other cancer cell lines suggesting a harmful effect of CPT on normal cells. Same is the case forin vivo roots and bark extracts. Leaves showed moderate activity on every cell lines butin vitro shoot and callus cultures showed the best activity on cancer cells with comparatively low activity on normal cells. This observation suggested that these extracts probably act selectively on cancer cells.
Maximum CPT is known to present in the root, bark, and leaves extracts as compared toin vitro plantlets and callus extracts  whereas the antiproliferative effect was seen to be maximum in the extracts inin vitro plantlets and callus extracts which has lower amount of CPT or in hexane extracts where CPT is absent. The presence of higher antiproliferating activity by extracts with low or no presence of CPT content as compared to standard CPT indicates the presence of other antiproliferative compounds in the extracts. Anticancer molecules such as CPT show severe side effects on normal cells, on the other hand, in this experiment extracts with low CPT or no CPT with high activity on cancer cell line showed very low toxicity toward normal cell line suggesting reduced side effects. When a combination of compounds exhibits a more potent therapeutic effect than that of individual compounds, the effect is described to be a synergistic. This type of mode of action offers an opportunity for more precise control of biological systems.
In vitro shoot and callus of C. fragrans strongly inhibited all the cancer cell lines (HT29, A549, and A431) with percent inhibition ranging from 1 to 18% whereas it showed 0.5–4% inhibition of murine fibroblast cell line (L929). Standard CPT showed 5–10% inhibition of cancer cell lines (HT29, A549, and A431) and 15% inhibition for murine fibroblast cell line (L929). These results are indicating that thein vitro shoots and callus extracts exhibit comparatively higher inhibition of growth of cancer cell lines compared to CPT.
In-vitro cytotoxicity analysis using MTT assays indicated that this plant is very effective and could inhibit the proliferation of different cancerous cell lines such as A431 (human epidermoidal carcinoma cell line), A549 (human lung carcinoma cell line), and HT29 (human colon epithelium cell line) suggesting the potential of C. fragrans as an anticancer agent. The most potent extracts werein vitro shoots and callus extracts which also showed selectivity toward cancer cells whereas roots, bark, and leaves extracts were less toxic to cancer cells. Considering the need of exploring the possible mechanism of action, further assays were carried out to understand inhibition of various key enzymes playing role in replication.
Topo is one of the crucial enzymes for cellular genetic processes, such as DNA replication, transcription. Topo I is known to relax the supercoilled DNA in the absence of an energy cofactor, by nicking the DNA and allowing rotation of the broken strand around the Topo I-bound DNA strand. The inhibition of DNA Topo I has proven to be a successful approach in designing of anticancer drugs.
In the MTT cell proliferation assay, callus extracts have shown highest activity against HT29 (human colon epithelium cell line), A549 (human lung carcinoma cell line), and A431 (human epidermoidal carcinoma cell line) as compared toin vivo roots, bark, and leaves extracts as well as standard anticancer drug CPT. Whereas it did not show antiproliferative effect against L929 (normal murine fibroblast cell line) which supports the observation that the callus extracts are selectively killing cancerous cell line. In human Topo I inhibition assay, callus extract of chloroform have shown superior inhibition of human Topo I activity as compared to in vivo extracts. This suggested that Topo I inhibition by this extract might be a possible mechanism for its strong anticancer activity where it can inhibit cancer cell lines.
In vitro shoot extracts proved to be weak inhibitors of E. coli Topo I activity while crude methanol extracts of roots, bark, leaves, and callus extracts did not inhibit the activity of Topo I and caused complete relaxation of plasmid DNA indicating that allin vitro shoots extracts were weak inhibitors of E. coli Topo I and allowed E. coli Topo I to relax the plasmid DNA. We can observe that root and bark sequential extracts are also inhibitors of E. coli Topo I, but these extracts also showed inhibitory effect on L929, therefore cannot consider having selective antiproliferation potential.
In our previous finding, quantification of the extracts by HPLC and HPTLC has showed that the content of CPT was lowest in hexane extracts ofin vitro shoots and callus. Our results have showed that these extracts were promising Topo I inhibitors as compared to extracts which showed highest CPT content (methanol extracts). This was thought to be due to the synergistic effect of compounds in extracts with high activity or antagonistic effect of various compounds in the extracts with low activity in spite of presence of high CPT.
Strong activity of ethyl acetate and hexane extract of callus confirmed mechanism of action is through Topo I inhibition. Here, we can clearly observe that ethyl acetate extracts of bark and ethyl acetate extracts of leaves were also strongly inhibiting the activity as no relaxed form is seen in a gel [Figure 2]b.
Ethyl acetate extract of leaves and bark showed strong inhibition of human Topo I. According to previous reports, both the extracts contain high CPT thanin vitro extracts (callus and shoots). As ethyl acetate extract of bark showed greater inhibition of normal cells too, bark was not considered as having anticancer potential but was considered to be cytotoxic in nature.
Topo II makes transient breaks in both strands of one DNA molecule allowing the passage of another DNA duplex through the gap and changing the linking number by steps of two. Topo II inhibitory activity was also analyzed to find out the probable mechanism for anticancer activity of these extracts as cancer cells rely on these enzyme more than healthy cells, since they divide more rapidly, and therefore this enzyme is one of the targets in developing anticancer assay.
The results suggested that all the extracts are weak inhibitors of Human Topo II enzymes. From previous results, the extracts were thought to have inhibitory effect on Human Topo I activity.
All the extracts were proved to have weak human Topo II inhibitory activity. According to Pavillard et al., who explored the cytotoxicity of combinations of a Topo I inhibitor (CPT) and a Topo II inhibitor (doxorubicin or etoposide) at several molar ratios, the simultaneous combination of Topo I and Topo II inhibitor was antagonistic in C6 cells. The cytotoxicity of etoposide (Topo inhibitor) was diminished in the presence of CPT. Likewise, treatment with CPT diminished the cytotoxicity of Topo II inhibitors, namely, aminoacridine [4-(9-acridinylamlno)-N~(methanesulfonyl)-m-anisidine] and anthracycline dau norubicin. CPT also antagonized the cytotoxicity of 4'-(9-acridinylamino) methanesulfon-M-anisidide and daunorubicin, two structurally unrelated Topo II-directed agents. Topotecan, a CPT analog currently undergoing Phase I clinical trials, had a similar effect. This suggests that CPT reduces the cytotoxicity of different, structurally distinct Topo II directed chemotherapeutic agents. An inhibitory effect of CPT on etoposide induced cytotoxicity was observable at concentrations of CPT as low as 0.01 µM. These results have proved that CPT shows inhibitory effect in presence of Topo II inhibitors. In this case, also, presence of CPT could be related to the weak activity of Topo II inhibitory activity of C. fragrans extracts.
In case of hexane extracts, although CPT is absent, the extracts have shown presence of Topo I inhibitors. Literature survey has revealed that presence of Topo I inhibitor (CPT) gives antagonistic effect to Topo II inhibitor and vice versa. Same could be the reason for weak Topo II inhibitory activity of hexane extracts.
DNA pol is actively being targeted for the development of novel anticancer agents. The most common method used to measure DNA pol activityin vitro depends upon the incorporation of radiolabel nucleotides. However, routine use of such assays is detrimental due to risks and restrictions associated with radioisotopes. We have used a rapid, highly sensitive, and quantitative assay capable of measuring DNA pol extension activity. This fluorescence-based assay measures the inhibition of DNA pol activity on the basis of specific reaction of the dye PicoGreen with double-stranded DNA.
The extracts showed highest inhibition of DNA pol activity as compared to activity of pure CPT (13.09%) at 8 µg suggesting that mere presence of CPT is not responsible for this DNA pol inhibition. It should be noted that chloroform extract ofin vitro shoots and methanol extract of leaves showed highest activity at lowest concentration (4 µg). Lowest activity was seen in CPT (13.90%) at 8 µg, hexane extract of callus (16.48%) at 8 µg whereas ethyl acetate extract of bark and methanol extract of callus showed negative activity.
The study also indicates good DNA pol inhibitory activity of C. fragrans suggesting that the extracts have a potential of inhibiting DNA polymerase at low concentration. The inhibitors of DNA pol has been reported to impair the growth of cancer cells.
| Conclusion|| |
We can arrive at the conclusion that this plant further needs to be explored in detail forin vivo cancer studies. From MTT assay, we have concluded that chloroform extract of callus is a potent anticancer agent showing Topo I (E. coli and human) inhibitory activity and also is an inhibitor of DNA pol. The plant has promising anticancer activity against human colon epithelium, lung carcinoma, and epidermoidal carcinoma. This study is the first report of exploring the antiproliferative potential and probable mechanism of action using crude and sequential extracts of C. fragrans. From different assays, a potent anticancer potential of chloroform extract of callus was revealed showing Topo I (E. coli and human) inhibitory activity, DNA pol inhibitory activity suggesting that different compounds are contributing different activities. Also, synergistic effect of compounds was thought to be responsible for inhibitory activity of Topo I as well as DNA pol from C. fragrans extracts as seen from the results of hexane extracts. Considering the importance of these activities, the extracts should be further explored for its metabolite content.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Kulkarni AV, Patwardhan AA, Lele U, Malpathak NP. Production of camptothecin in cultures of Chonemorpha grandiflora
. Pharmacognosy Res 2010;2:296-9.
Shende V, Sawant V, Turuskar A, Chatap V, Vijaya C. Evaluation of hypoglycemic and antihyperglycemic effects of alcoholic extract of Chonemorpha fragrans
root in normal and alloxan induced diabetic rats. Pharmacogn Mag 2009;5:36-41.
Rai P, Lalramnghinglova H. Ethnomedicinal plant resources of Mizoram, India: Implication of traditional knowledge in health care system. Ethnobotanical Leaflets 2010;14:274-305.
Kulkarni A, Patwardhan A, Upadhye S, Malpathak N. Pharmacognostic evaluation of Chonemorpha grandiflora
, an endangered medicinal plant. Indian J Pharm Sci Res 2011;2:2690-3.
Lorence A, Medina-Bolivar F, Nessler CL. Camptothecin and 10-hydroxycamptothecin from Camptotheca acuminata
hairy roots. Plant Cell Rep 2004;22:437-41.
Vijayan P, Vijayaraj P, Setty PH, Hariharpura RC, Godavarthi A, Badami S, et al.
The cytotoxic activity of the total alkaloids isolated from different parts of Solanum pseudocapsicum
. Biol Pharm Bull 2004;27:528-30.
Lavie Y, Harel-Orbital T, Gaffield W, Liscovitch M. Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells. Anticancer Res 2001;21:1189-94.
Ali R, Mirza Z, Ashraf GM, Kamal MA, Ansari SA, Damanhouri GA, et al.
New anticancer agents: Recent developments in tumor therapy. Anticancer Res 2012;32:2999-3005.
Pasi A, Sharma P, Pandey P, Gupta R, Bhandarkar S. A silent crisis: Recent drug discovery in cancer research. Int J Pharm Rev Res 2013;3:74-7.
Kedari P, Malpathak N. Subcellular localization and quantification of camptothecin in different plant parts of Chonemorpha fragrans.
Adv Zool Bot 2013;1:34-8.
Nemati F, Dehpouri AA, Eslami B, Mahdavi V, Mirzanejad S. Cytotoxic properties of some medicinal plant extracts from Mazandaran, Iran. Iran Red Crescent Med J 2013;15:e8871.
Diwan R, Malpathak N. Furanocoumarins: Novel topoisomerase I inhibitors from Ruta graveolens
L. Bioorg Med Chem 2009;17:7052-5.
Sun NJ, Woo SH, Cassady JM, Snapka RM. DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia
. J Nat Prod 1998;61:362-6.
Tveit H, Kristensen T. Fluorescence-based DNA polymerase assay. Anal Biochem 2001;289:96-8.
Tong-Jen F. Why are the products of cell suspension cultures different? Chemtech 1998;28:40-6.
Parasramka MA, Gupta SV. Synergistic effect of garcinol and curcumin on antiproliferative and apoptotic activity in pancreatic cancer cells. J Oncol 2012;2012:709739.
Kuhn J, Burris S, Wall J, Brown T, Cagnola J, Havlin K, et al
. Pharmacokinetics of the topoisomerase I inhibitor, SK and F
104864. Proc Am Soc Clin Oncol 1990;9:70-6.
Dexheimer TS, Pommier Y. DNA cleavage assay for the identification of topoisomerase I inhibitors. Nat Protoc 2008;3:1736-50.
Hande K. Etoposide: Four decades of development of a topoisomerase II inhibitor. Eur J Cancer 1998;34:1514-21.
Pavillard V, Kherfellah D, Richard S, Robert J, Montaudon D. Effects of the combination of camptothecin and doxorubicin or etoposide on rat glioma cells and camptothecin-resistant variants. Br J Cancer 2001;85:1077-83.
Richardson CC, Schildkraut CL, Aposhian HV, Kornberg A. Enzymatic synthesis of deoxyribonucleic acid. xiv. Further purification and properties of deoxyribonucleic acid polymerase of Escherichia coli
. J Biol Chem 1964;239:222-32.
Zweitzig DR, Riccardello NM, Sodowich BI, O'Hara SM. Characterization of a novel DNA polymerase activity assay enabling sensitive, quantitative and universal detection of viable microbes. Nucleic Acids Res 2012;40:e109.
Jaiswal AS, Banerjee S, Panda H, Bulkin CD, Izumi T, Sarkar FH, et al.
A novel inhibitor of DNA polymerase beta enhances the ability of temozolomide to impair the growth of colon cancer cells. Mol Cancer Res 2009;7:1973-83.
| Authors|| |
Dr. Nutan Padmanabh Malpathak is currently working as professor in Department of Botany, Savitribai Phule Pune University. Author actively works on Plant tissue culture, Secondary Metabolites, Metabolic Fingerprinting, Bioactivity assessment and Bio-prospecting. Author has many Publications to her name.
[Figure 1], [Figure 2], [Figure 3]